XNK Therapeutics
Vera Franzén has long experience from the Swedish pharmaceutical industry, working in senior positions within pharmaceutical development, quality control and regulatory affairs. She has also worked as Head of Section at the Medical Products Agency and as Regulatory Affairs Director at SentoClone, one of the first Swedish ATMP companies.
This person is not in the org chart
This person is not in any offices
XNK Therapeutics
XNK Therapeutics is focused on realizing the potential in autologous NK cell therapies for cancer patients.